Understanding the pathways that signal T cell tolerance versus activation is key to regulating immunity. Previous studies have linked CD28 and protein kinase C-θ (PKCθ) as a potential signaling pathway that influences T cell activation. Therefore, we have compared the responses of T cells deficient for CD28 and PKCθ in vivo and in vitro. Here, we demonstrate that the absence of PKCθ leads to the induction of T cell anergy, with a phenotype that is comparable to the absence of CD28. Further experiments examined whether PKCθ triggered other CD28-dependent responses. Our data show that CD4 T cell–B cell cooperation is dependent on CD28 but not PKCθ, whereas CD28 costimulatory signals that augment proliferation can be uncoupled from signals that regulate anergy. Therefore, PKCθ relays a defined subset of CD28 signals during T cell activation and is critical for the induction of activation versus tolerance in vivo.
Skip Nav Destination
Article navigation
15 March 2004
Article|
March 15 2004
PKCθ Signals Activation versus Tolerance In Vivo
Nancy N. Berg-Brown,
Nancy N. Berg-Brown
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Matthew A. Gronski,
Matthew A. Gronski
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Russell G. Jones,
Russell G. Jones
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Alisha R. Elford,
Alisha R. Elford
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Elissa K. Deenick,
Elissa K. Deenick
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Bernhard Odermatt,
Bernhard Odermatt
2Department of Pathology, University of Zurich, 8091 Zurich, Switzerland
Search for other works by this author on:
Dan R. Littman,
Dan R. Littman
3Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016
Search for other works by this author on:
Pamela S. Ohashi
Pamela S. Ohashi
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Search for other works by this author on:
Nancy N. Berg-Brown
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Matthew A. Gronski
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Russell G. Jones
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Alisha R. Elford
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Elissa K. Deenick
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Bernhard Odermatt
2Department of Pathology, University of Zurich, 8091 Zurich, Switzerland
Dan R. Littman
3Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016
Pamela S. Ohashi
1Ontario Cancer Institute, University Health Network, Toronto, Ontario, M5G 2M9 Canada
Address correspondence to Pamela S. Ohashi, Ontario Cancer Institute, University Health Network, 610 University Ave., Toronto, Ontario, M5G 2M9 Canada. Phone: (416) 946-4501; Fax: (416) 946-2086; email: [email protected]
Abbreviations used in this paper: CFSE, carboxyfluorescein diacetate succinimidyl ester; CTL, cytotoxic T lymphocyte; gp, glycoprotein; JNK, c-Jun NH2-terminal kinase; LCMV, lymphocytic choriomeningitis virus; PKCθ, protein kinase C-θ; SMAC, supramolecular activation complex; VSV, vesicular stomatitis virus.
Received:
June 24 2003
Accepted:
January 28 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 199 (6): 743–752.
Article history
Received:
June 24 2003
Accepted:
January 28 2004
Citation
Nancy N. Berg-Brown, Matthew A. Gronski, Russell G. Jones, Alisha R. Elford, Elissa K. Deenick, Bernhard Odermatt, Dan R. Littman, Pamela S. Ohashi; PKCθ Signals Activation versus Tolerance In Vivo . J Exp Med 15 March 2004; 199 (6): 743–752. doi: https://doi.org/10.1084/jem.20031022
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement